HOME >> BIOLOGY >> NEWS
2nd annual Albert Szent-Gyrgyi Prize for Progress in Cancer Research awarded to Webster K. Cavenee

(January 17, 2007, Bethesda, MD) -- The National Foundation for Cancer Research (NFCR) announced today that Webster K. Cavenee, Ph.D. has been awarded the 2nd Annual Albert Szent-Gyrgyi Prize for Progress i n Cancer Research. Dr. Cavenee, Director of the Ludwig Institute for Cancer Research and Distinguished Professor at the University of California, San Diego, won the prize for his groundbreaking discoveries regarding the genetic mechanisms of predisposition to human cancer. Dr. Cavenee's research provided the first genetic evidence for the existence of tumor suppressor genes, one of the most influential breakthroughs in cancer research.

The annual Albert Szent-Gyrgyi Prize for Progress in Cancer Research was established to recognize outstanding scientific achievement in the war against cancer and to honor pioneering scientists who have made extraordinary contributions in the field of cancer research. The Prize is designed to draw attention to the continued need to support basic cancer research and the role that it plays in new cancer therapies. The Prize includes a $25,000 honorarium.

"Dr. Cavenee is a pioneer in the truest sense of the word. His research on tumor suppressor genes has not only advanced our understanding of cancer, but it also has provided valuable insight in the role that hereditary predisposition plays into developing cancer," said Dr. Harold Dvorak of Beth Israel Deaconess Hospital and Chair of the Szent-Gyrgyi Prize Selection Committee.

"Dr. Cavenee's discoveries have helped to pave the way for researchers to better break down cancer's complicated molecular structures and understand the role that tumor suppressor genes play in cancer growth and development," said Dr. Sujuan Ba, Co-Chair of the Szent-Gyrgyi Prize Selection Committee and Chief Scientific Officer of NFCR.

Dr. Cavenee's original research seeking to define the genetic lesions in retinoblastoma led to the first hard experimental evi
'"/>

Contact: Silas Deane
sdeane@nfcr.org
National Foundation for Cancer Research
17-Jan-2007


Page: 1 2 3

Related biology news :

1. SNM capitalizes opportunity to meet with policymakers, regulators at annual meeting in D.C.
2. AACR, FDA and NCI announce cancer biomarkers collaborative at the AACR 2007 annual meeting
3. Second annual stem cell symposium to focus on heart tissue, blood diseases
4. Sixth annual bioethics forum to tackle medical applications of research
5. University of Minnesotas 6th annual Design of Medical Devices Conference to be held April 17-19
6. AACR hosts annual meeting 2007
7. Third annual Templeton-Cambridge Fellowships awarded to 10 noted journalists
8. National Academies sessions at AAAS 2007 annual meeting, Feb. 16-19
9. Wiley Foundation announces recipients of 6th annual Wiley Prize in Biomedical Sciences
10. 48th annual Drosophila Research Conference, Philadelphia Marriott, March 7-11, 2007
11. New studies on Alzheimers, autism, nicotine addiction and depression highlight annual meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2019)... SASKATOON, Canada (PRWEB) , ... February 12, 2019 ... ... immediately it will begin operating under its new name, KEYLEAF. The company ... more of its own plant-based extracts and ingredients as finished products under the ...
(Date:2/2/2019)... ... January 31, 2019 , ... ... geared toward clinical operations executives and focusing on all facets of clinical trial ... project management, portfolio management, resource management, patient engagement, and more. , “We ...
(Date:1/25/2019)... ... January 24, 2019 , ... ... PhD, Assistant Professor of Microbiology at the Jackson Laboratory (JAX), to its Scientific ... world, Dr. Oh will bring to uBiome expertise in skin microbial interactions and ...
Breaking Biology News(10 mins):
(Date:2/12/2019)... ... February 12, 2019 , ... ... has finalized a deal to extend their use of Medrio, the leading provider ... 2023. The CRO has been a regular Medrio customer for over nine years, ...
(Date:2/2/2019)... ... , ... Signature Matrix and Signature Cord are the culmination ... cell research expert and Amazon best-selling author, Neil Riordan, PA, PhD, and his ... allograft that originates from the same tissue used to manufacture the purified, expanded ...
(Date:1/30/2019)... ... January 29, 2019 , ... ... Lifecycle since 2016. In his position as Director of Sales and Marketing, Mr. ... services supplier across multiple industries the company supports. During this time, Mr. Schieving ...
(Date:1/30/2019)... ... January 30, 2019 , ... The Society for Laboratory ... to discuss best practices for laboratory automation and screening. This year the conference ... year’s conference, Visikol will be at booth #345 and throughout the conference will ...
Breaking Biology Technology:
Cached News: